Gary Loeb compensation by year
INTUITIVE SURGICAL Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $615,000 |
| Bonus | $0 |
| Stock awards | $4,254,731 |
| Option awards | $0 |
| Non-equity incentive | $708,480 |
| Pension and deferred compensation | $0 |
| All other | $12,000 |
| Total | $5,590,211 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INTUITIVE SURGICAL INC DEF 14A filed March 13, 2026, accession 0001035267-26-000023, and prior-year filings.
How this page was built: the INTUITIVE SURGICAL INC filed document, accession 0001035267-26-000023. Every figure is read from that document and cited to the page and table it appears in. Filed March 13, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 5,086 | $2,880,507 | — |
| RSU | 4,578 | $2,592,796 | — |
| RSU | 4,577 | $2,592,230 | — |
| RSU | 3,662 | $2,074,010 | — |
| RSU | 2,612 | $1,479,332 | — |
| RSU | 2,543 | $1,440,253 | — |
| RSU | 2,098 | $1,188,223 | — |
| PSU | 1,050 | $594,678 | — |
| RSU | 629 | $356,240 | — |
| Option | 551 | — | $304.67 |
| Option | 2,177 | — | $186.55 |
| Option | 551 | — | $229.39 |
Per the Outstanding Equity Awards at Fiscal Year-End table in INTUITIVE SURGICAL INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
6 Form 4 lines since the FY2025 proxy (filed March 13, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-10 | Tax withholding | — | 1,296 | $423.96 | 6,636 |
| 2026-10-10 | Exercise or conversion | — | 2,612 | $0.00 | 7,932 |
| 2026-10-10 | Exercise or conversion derivative | — | 2,612 | $0.00 | 0 |
| 2026-08-10 | Sale | 10b5-1 | 400 | $379.00 | 5,320 |
| 2026-06-10 | Sale | 10b5-1 | 400 | $424.14 | 5,720 |
| 2026-05-11 | Sale | 10b5-1 | 400 | $446.95 | 6,120 |
The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
INTUITIVE SURGICAL’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Rosa | Chief Executive Officer | $20,997,480 |
| Gary Guthart | Executive Chair of the Board of Directors | $18,094,937 |
| Jamie Samath | Executive Vice President, Chief Financial Officer and Enterprise Technology Leader | $8,396,045 |
| Henry Charlton | Executive Vice President and Chief Commercial and Marketing Officer | $6,240,703 |
| Gary Loeb · this page | Executive Vice President and Chief Legal and Compliance Officer | $5,590,211 |
| Mark Brosius | Senior Vice President and Chief Manufacturing and Supply Chain Officer | $5,539,390 |
Gary Loeb's compensation dossier, INTUITIVE SURGICAL
You have read Gary Loeb's totals and holdings. The dossier adds each equity grant INTUITIVE SURGICAL disclosed for Gary Loeb and INTUITIVE SURGICAL's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full INTUITIVE SURGICAL compensation record
free company briefThis page is one person within INTUITIVE SURGICAL's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the INTUITIVE SURGICAL proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order INTUITIVE SURGICAL's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are INTUITIVE SURGICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.